(Q44985087)

8 December 2017

title

Single-agent pulse dactinomycin has only modest activity for methotrexate-resistant gestational trophoblastic neoplasia (English)

1 reference

8 December 2017

1 reference

2

1 reference

8 December 2017

Lee-May Chen

1

1 reference

8 December 2017

C Bethan Powell

series ordinal

3

1 reference

8 December 2017

language of work or name

English

0 references

publication date

1 July 2004

1 reference

8 December 2017

1 reference

8 December 2017

volume

94

1 reference

8 December 2017

issue

1

1 reference

8 December 2017

page(s)

204-207

1 reference

The new FIGO 2000 staging and risk factor scoring system for gestational trophoblastic disease: description and critical assessment

8 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.04.018

Actinomycin D as the primary agent for gestational trophoblastic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.04.018

Actinomycin D toxicity in the treatment of trophoblastic disease: a comparison of the five-day course to single-dose administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.04.018

Pulse actinomycin D scheduling in nonmetastatic gestational trophoblastic neoplasia: Cost-effective chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.04.018

Single-dose actinomycin D in the treatment of postmolar trophoblastic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.04.018

Single-dose actinomycin-D treatment for nonmetastatic gestational trophoblastic disease. A prospective phase II trial of the Gynecologic Oncology Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.04.018

Low-risk persistent gestational trophoblastic disease: outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.04.018

Is lack of response to single-agent chemotherapy in gestational trophoblastic disease associated with dose scheduling or chemotherapy resistance?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.04.018

10.1016/J.YGYNO.2004.04.018

7 January 2021

Identifiers

DOI

1 reference

8 December 2017

1 reference